Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$45.12 - $53.8 $777,192 - $926,705
-17,225 Closed
0 $0
Q4 2018

Feb 15, 2019

SELL
$48.76 - $63.23 $1.27 Million - $1.64 Million
-25,955 Reduced 60.11%
17,225 $895,000
Q3 2018

Nov 15, 2018

SELL
$55.19 - $62.25 $1.46 Million - $1.64 Million
-26,400 Reduced 37.94%
43,180 $0
Q2 2018

Aug 15, 2018

BUY
$50.53 - $62.98 $3.52 Million - $4.38 Million
69,580 New
69,580 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sentinel Trust CO Lba Portfolio

Follow Sentinel Trust CO Lba and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sentinel Trust CO Lba, based on Form 13F filings with the SEC.

News

Stay updated on Sentinel Trust CO Lba with notifications on news.